Here you will find the latest publications related to the companies that are part of the Peaches Biotech group.
Each article contains the link to the page where the news is published.
International Cancer Research Day
We share with you this interesting interview in Con Salud, one of the leading media in the health sector, about our novel and promising approach to pancreatic cancer treatment. Juan Carlos de Gregorio, our CEO and founder, explains in plain language the advances...
A new approach for the treatment of infection-associated cytokine storm.
Did you know that cytokine storm, associated with severe infectious processes, is a serious global health problem for which there is no effective drug for treatment? Peaches Biotech's Chief Scientific Officer publishes results of his research against the cytokine...
“We are closer and a cure for pancreatic cancer will be feasible.”
Interview with Manuel Hidalgo, research associate at Peaches Biotech, in the supplement A tu Salud of La razón. Research talent is one of our company's greatest assets. On this occasion, Manuel Hidalgo, Director of the Division of Hematology-Oncology at Weill Cornell...
Peaches Biotech is working on a new approach against pancreatic cancer.
Tribune published in El Economista Our CEO, Juan Carlos de Gregoriohas had the opportunity to publish in The Economist a forum where he shares his vision on the current treatments for pancreatic cancer, as well as the new approach proposed by Peaches against...
New biotechnology platform enables production of complex biologic drugs for allogeneic use
Combined in silico and experimental research to test the potential immunogenicity of a new complex biologic drug (PRS CK STORM). The American Journal of Biomedical Science and Research has published and endorsed a new article on our drug PRS CK STORM. You can...
Peaches Biotech publishes positive in vivo results of its drug PRS CK STORM
Peaches Biotech publishes positive in vivo results of its drug PRS CK STORM against cytokine storm associated with infectious processes
Intercellular communication (crosstalk) to fight inflammation and fibrosis
Design of new biological drugs At Peaches Biotech we continue to advance in the dissemination of the concept and the possibilities that open up with intercellular communication (crosstalk) and its therapeutic possibilities. The publication in the American Journal of...
Peaches Biotech deciphers communication language between immune cells and other tissues
Peaches Biotech publishes in Biomolecules its work on how the immune system communicates with tissues damaged or attacked by viruses or bacteria. This breakthrough opens a way to find new drugs, of biological origin, of great importance in advanced therapies such as...
“Our approach is very mindful of the specificity of each tumor in each patient.”
The online healthcare newspaper Con Salud has interviewed our research associate, Dr. Senthil Muthuswamy, Director of Translational Research at the Beth Israel Deaconess Hospital Cancer Center in Boston, and published in detail what the platform consists of. opT of...
C/ Isabel Colbrand 6
4ª Planta B
28050 Madrid (Spain)
L - J : 9:00–18:00 hs
V : 9:00–15:00 hs